Skip to main content

Healthy Adult

10
Pipeline Programs
8
Companies
14
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
10
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Jeil Pharmaceutical
Jeil PharmaceuticalKorea - Seoul
3 programs
3
JLP-1901Phase 11 trial
JLP-2004Phase 11 trial
SGLT2 inhibitorPhase 11 trial
Active Trials
NCT06171880Completed48Est. May 2022
NCT06169059Completed60Est. Nov 2023
NCT06165965Completed48Est. Jun 2022
Dong-A ST
Dong-A STKorea - Seoul
2 programs
2
DA-5223Phase 11 trial
DA-5223-RPhase 11 trial
Active Trials
NCT07007520Recruiting38Est. Nov 2025
NCT07007533Completed38Est. Jul 2025
Daewon Pharma
Daewon PharmaKorea - Hwaseong
2 programs
2
DW4421Phase 11 trial
DW5524Phase 11 trial
Active Trials
NCT07343245Recruiting150Est. Jun 2026
NCT07349589Not Yet Recruiting48Est. Dec 2026
Sonnet BioTherapeutics
1 program
1
SON-1010Phase 1
BioTherapeutics Inc
BioTherapeutics IncVA - Blacksburg
1 program
1
SON-1010Phase 11 trial
Active Trials
NCT05408572Completed32Est. May 2023
Voronoi
VoronoiKorea - Incheon
1 program
1
VRN101099Phase 11 trial
Active Trials
NCT07550946Not Yet Recruiting24Est. Sep 2026
Eisai
EisaiChina - Liaoning
2 programs
Donepezil HydrochloridePHASE_11 trial
Donepezil HydrochloridePHASE_11 trial
Active Trials
NCT01506739Completed12Est. May 2011
NCT01506752Completed20Est. Sep 2011
Bristol Myers Squibb
1 program
BMS-986142PHASE_13 trials
Active Trials
NCT02880670Completed9Est. Sep 2016
NCT02832180Completed25Est. Oct 2016
NCT02257151Completed118Est. Aug 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
VoronoiVRN101099
Daewon PharmaDW5524
Daewon PharmaDW4421
Dong-A STDA-5223
Dong-A STDA-5223-R
Jeil PharmaceuticalJLP-2004
BioTherapeutics IncSON-1010
Jeil PharmaceuticalSGLT2 inhibitor
Jeil PharmaceuticalJLP-1901
Bristol Myers SquibbBMS-986142
Bristol Myers SquibbBMS-986142
Bristol Myers SquibbBMS-986142
EisaiDonepezil Hydrochloride
EisaiDonepezil Hydrochloride

Clinical Trials (14)

Total enrollment: 670 patients across 14 trials

Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN101099 in Healthy Adult Participants

Start: May 2026Est. completion: Sep 202624 patients
Phase 1Not Yet Recruiting

Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers

Start: Feb 2026Est. completion: Dec 202648 patients
Phase 1Not Yet Recruiting

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

Start: Dec 2025Est. completion: Jun 2026150 patients
Phase 1Recruiting

A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects

Start: Nov 2025Est. completion: Nov 202538 patients
Phase 1Recruiting

A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects

Start: Jul 2025Est. completion: Jul 202538 patients
Phase 1Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004

Start: Oct 2023Est. completion: Nov 202360 patients
Phase 1Completed

Study of SON-1010 (IL12-FHAB) in Healthy Adults

Start: Jul 2022Est. completion: May 202332 patients
Phase 1Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008

Start: May 2022Est. completion: Jun 202248 patients
Phase 1Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901

Start: Feb 2022Est. completion: May 202248 patients
Phase 1Completed

Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects

Start: Aug 2016Est. completion: Sep 20169 patients
Phase 1Completed

The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects

Start: May 2016Est. completion: Oct 201625 patients
Phase 1Completed

Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects

Start: Sep 2014Est. completion: Aug 2015118 patients
Phase 1Completed
NCT01506752EisaiDonepezil Hydrochloride

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

Start: Jul 2011Est. completion: Sep 201120 patients
Phase 1Completed
NCT01506739EisaiDonepezil Hydrochloride

A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males

Start: Mar 2011Est. completion: May 201112 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 670 patients
8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.